These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Biochemical and immunological characterization of the plant-derived candidate human immunodeficiency virus type 1 mucosal vaccine CTB-MPR. Matoba N, Kajiura H, Cherni I, Doran JD, Bomsel M, Fujiyama K, Mor TS. Plant Biotechnol J; 2009 Feb; 7(2):129-45. PubMed ID: 19037902 [Abstract] [Full Text] [Related]
4. Development and immunological assessment of VLP-based immunogens exposing the membrane-proximal region of the HIV-1 gp41 protein. Benen TD, Tonks P, Kliche A, Kapzan R, Heeney JL, Wagner R. J Biomed Sci; 2014 Aug 27; 21(1):79. PubMed ID: 25160824 [Abstract] [Full Text] [Related]
5. Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles. Phogat S, Svehla K, Tang M, Spadaccini A, Muller J, Mascola J, Berkower I, Wyatt R. Virology; 2008 Mar 30; 373(1):72-84. PubMed ID: 18155743 [Abstract] [Full Text] [Related]
9. The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes. Alam SM, McAdams M, Boren D, Rak M, Scearce RM, Gao F, Camacho ZT, Gewirth D, Kelsoe G, Chen P, Haynes BF. J Immunol; 2007 Apr 01; 178(7):4424-35. PubMed ID: 17372000 [Abstract] [Full Text] [Related]
11. Modulation of nonneutralizing HIV-1 gp41 responses by an MHC-restricted TH epitope overlapping those of membrane proximal external region broadly neutralizing antibodies. Zhang J, Alam SM, Bouton-Verville H, Chen Y, Newman A, Stewart S, Jaeger FH, Montefiori DC, Dennison SM, Haynes BF, Verkoczy L. J Immunol; 2014 Feb 15; 192(4):1693-706. PubMed ID: 24465011 [Abstract] [Full Text] [Related]
12. N-terminal residues of an HIV-1 gp41 membrane-proximal external region antigen influence broadly neutralizing 2F5-like antibodies. Li D, Liu J, Zhang L, Xu T, Chen J, Wang L, Zhao Q. Virol Sin; 2015 Dec 15; 30(6):449-56. PubMed ID: 26715302 [Abstract] [Full Text] [Related]
16. Induction of HIV neutralizing antibodies against the MPER of the HIV envelope protein by HA/gp41 chimeric protein-based DNA and VLP vaccines. Ye L, Wen Z, Dong K, Wang X, Bu Z, Zhang H, Compans RW, Yang C. PLoS One; 2011 Dec 15; 6(5):e14813. PubMed ID: 21625584 [Abstract] [Full Text] [Related]
19. Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. Zwick MB, Labrijn AF, Wang M, Spenlehauer C, Saphire EO, Binley JM, Moore JP, Stiegler G, Katinger H, Burton DR, Parren PW. J Virol; 2001 Nov 15; 75(22):10892-905. PubMed ID: 11602729 [Abstract] [Full Text] [Related]
20. Antigenic and immunogenic study of membrane-proximal external region-grafted gp120 antigens by a DNA prime-protein boost immunization strategy. Law M, Cardoso RM, Wilson IA, Burton DR. J Virol; 2007 Apr 15; 81(8):4272-85. PubMed ID: 17267498 [Abstract] [Full Text] [Related] Page: [Next] [New Search]